Hypoparathyroidism-retardation-dysmorphism syndrome-Clinical insights from a large longitudinal cohort in a single medical center
- PMID: 35935360
- PMCID: PMC9352926
- DOI: 10.3389/fped.2022.916679
Hypoparathyroidism-retardation-dysmorphism syndrome-Clinical insights from a large longitudinal cohort in a single medical center
Abstract
Background: Hypoparathyroidism, retardation, and dysmorphism (HRD) Syndrome is a rare disease composed of hypoparathyroidism, retardation of both growth and development, and distinctive dysmorphic features. Here, we describe the long-term morbidity and mortality in a large cohort of HRD patients and suggest recommendations for follow up and treatment.
Methods: Medical records of 63 HRD syndrome patients who were followed at Soroka Medical Center during 1989-2019 were reviewed retrospectively. Information regarding demographics, medical complications, laboratory findings, and imaging studies was collected.
Results: The mortality rate was 52%. The main causes of death were infectious diseases including pneumonia, septic shock, and meningitis. Multiple comorbidities were found including brain anomalies in 90% of examined patients (basal ganglia calcifications, tightening of corpus callosum, Chiari malformation, hydrocephalous, and brain atrophy), seizures in 62%, nephrocalcinosis and/or nephrolithiasis in 47%, multiple eye anomalies were recorded in 40%, bowel obstructions in 9.5%, and variable expression of both conductive and senso-neural hearing loss was documented in 9.5%.
Conclusion: HRD is a severe multisystem disease. Active surveillance is indicated to prevent and treat complications associated with this rare syndrome.
Keywords: HRD; Sanjad-Sakati; bowel obstruction; infections; nephrolithiasis; seizures.
Copyright © 2022 David, Agur, Novoa, Shaki, Walker, Carmon, Eskin-Schwartz, Birk, Ling, Schreiber, Loewenthal, Haim and Hershkovitz.
Figures

Similar articles
-
Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency.J Clin Immunol. 2023 Feb;43(2):350-357. doi: 10.1007/s10875-022-01380-9. Epub 2022 Oct 18. J Clin Immunol. 2023. PMID: 36258138 Free PMC article.
-
Neurological manifestations in children with Sanjad-Sakati syndrome.Int J Gen Med. 2013 May 27;6:393-8. doi: 10.2147/IJGM.S40930. Print 2013. Int J Gen Med. 2013. PMID: 23807856 Free PMC article.
-
Clinical features and tubulin folding cofactor E gene analysis in Iranian patients with Sanjad-Sakati syndrome.J Pediatr (Rio J). 2020 Jan-Feb;96(1):60-65. doi: 10.1016/j.jped.2018.07.005. Epub 2018 Aug 4. J Pediatr (Rio J). 2020. PMID: 30080992 Free PMC article.
-
Endocrinological Manifestations of Sanjad-Sakati Syndrome.Cureus. 2020 Jun 22;12(6):e8770. doi: 10.7759/cureus.8770. Cureus. 2020. PMID: 32714707 Free PMC article. Review.
-
Hypoparathyroidism-retardation-Dysmorphism (HRD) syndrome--a review.J Pediatr Endocrinol Metab. 2004 Dec;17(12):1583-90. doi: 10.1515/jpem.2004.17.12.1583. J Pediatr Endocrinol Metab. 2004. PMID: 15645691 Review.
Cited by
-
Expanding the Phenotypic Spectrum of Kenny-Caffey Syndrome.J Clin Endocrinol Metab. 2023 Aug 18;108(9):e754-e768. doi: 10.1210/clinem/dgad147. J Clin Endocrinol Metab. 2023. PMID: 36916904 Free PMC article.
References
LinkOut - more resources
Full Text Sources